GlassScriptPhysician profile
Melissa N Day
NPI 1215315759
$5,619.69
in general payments reported to CMS, 2019-2025
19 companies · $2,291 in 2025
The $2,291 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $164 · 2021: $397 · 2022: $528 · 2023: $1,334 · 2024: $632 · 2025: $2,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,997 · Travel and Lodging: $1,639 · Education: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,996.53 |
| Travel and Lodging | $1,638.55 |
| Education | $622.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,531.41 | 2023-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis |
| Penumbra, INC. | $975.92 | 2023-2025 | Indigo System, Penumbra System |
| Medtronic, INC. | $706.59 | 2021-2025 | Endurant Iis |
| Bolton Medical INC | $497.83 | 2023-2025 | Treo Abdominal Stent-Graft System |
| Bard Peripheral Vascular, INC. | $436.60 | 2021-2023 | |
| Lemaitre Vascular, INC. | $374.22 | 2022-2023 | Hydro Lemaitre Valvulotome |
| Endologix LLC | $213.47 | 2024-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Cook Medical LLC | $159.25 | 2020-2023 | Zenith |
| Abbott Laboratories | $140.91 | 2024 | Esprit |
| Portola Pharmaceuticals, LLC | $133.86 | 2019 | |
| Kerecis Limited | $128.67 | 2020-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ethicon US, LLC | $111.64 | 2019 | |
| Ossur Americas, INC. | $66.56 | 2024 | Rheo Knee |
| Getinge USA Sales, LLC | $35.21 | 2024 | Icast |
| Allergan, INC. | $31.56 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $31.50 | 2020 | |
| Misonix INC | $15.59 | 2020 | |
| Medtronic Vascular, INC. | $14.64 | 2019 | |
| Abbvie INC. | $14.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.